CRF1 Receptors as a Therapeutic Target for Irritable Bowel Syndrome
Year: 2006
Type: article
Source: Current Pharmaceutical Design
Authors: V. Martinez, Y. Tache
Institution: AstraZeneca (Sweden)
Language: English
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2065681060
